From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Mion, 24 Feb 2020 20:22:42 +0000
To: Marston, Hilary (NIH/NIAID) [E]
Subject: FW: chloroquine in COVID-19
Attachments: chloroquine. pdf

Let us discuss

Anthony S. Fauci, MD

Director

National Institute of Allergy and Infectious Diseases

Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD 20892-2520

Phone:

FAX: (301) 496-4409

E-mail:

The information in this e-mail and any of its attachments is confidential and may contain sensitive
information. It should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

 
 

From: Gatti, Philip < D
Sent: Monday, February 24, 2020 2:42 PM
To: Fauci, Anthony (NIH/NIAID) NCO >
Subject; FW: chloroquine in COVID-19

Dear Dr. Fauci,

Is there any indication/data to substantiate this claim from China (attached publication) that
chloroquine/hydroxychloroquine can decrease COVID-19 infections and lung disease?
Thank you,

Philip Gatti, Ph.D.

Pharmacologist

FDA

CDER

OND

Silver Spring, MD

NIH-001430
